# Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy

> **NCT05113394** · PHASE2 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Asthma
- Allergy

## Interventions

- **DRUG:** HDM sublingual Immunotherapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05113394
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2027-02-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Awaiting funding
- **Last updated:** 2024-11-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05113394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05113394, "Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05113394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*